It is unknown why certain individuals are more likely the develop this condition than others, but there are many potential triggers including certain bacteria, chewing gum, lip licking/sucking in children, dental products, topical steroids, certain spices, hormonal changes, certain medications, and autoimmune diseases
In the primary Phase 2 clinical trial published in the New England Journal of Medicine (Jastreboff et al., 2023), retatrutide was studied across several dose levels, including: 1 mg (low dose) 4 mg (mid dose) 8 mg (higher dose) 12 mg (highest dose) These doses were administered as once-weekly subcutaneous injections
FDA approval means they have passed the necessary efficacy and safety tests for public use
Semaglutide Hub Complete guide to Ozempic & Wegovy.